Acquisition Announcement
In a significant move aimed at becoming the world’s leading hearing aid company, Huizhou Jinghao Medical Technology Co., Ltd. has acquired Intricon’s Hearing Health business, assuming ownership and management of its hearing health assets starting September 11th, 2024. This acquisition strengthens Jinghao Medical’s global presence and lays a solid foundation for accelerating its expansion into international markets. By incorporating Intricon’s advanced algorithms, patented IP, and technology, Jinghao will further develop its product line and continue to push for technological advancements in hearing aids, hybrid chips, and global market growth.
The acquisition reflects Jinghao Medical’s commitment to integrating Intricon’s 47 years of proven expertise in hearing aid technology, firmware, and algorithms. Jinghao will also introduce foreign talent and innovation to ensure that the legacy of Intricon continues to serve the market at a higher standard. This acquisition marks a pivotal moment in Jinghao’s globalization journey and its strategic focus on becoming a global leader in the hearing health industry.
The perfect combination of two great companies
Huizhou Jinghao Medical Technology Co., Ltd. is China’s sole publicly listed hearing aid and hearing amplifier manufacturer. Renowned for providing high-quality, affordable hearing solutions, Jinghao serves both domestic and international markets with a broad range of hearing products, including behind-the-ear (BTE), in-the-ear (ITE), and bone conduction hearing aids. The company has built a solid reputation for innovation and affordability and is now poised to expand its market reach through this acquisition.
Intricon is a global leader in the development and supply of advanced hearing aid technology, with 47 years of experience in designing and manufacturing miniature hearing aids, components, and systems. Intricon is known for its established relationships with top audiology manufacturers and emerging innovators. The company has a strong backend infrastructure with operations in Singapore and Indonesia, and it has played a critical role in next-generation hearing aid programs.
The acquisition has significant benefits for all participants
This acquisition is a significant step towards Jinghao Medical’s long-term goal of becoming a global leader in the hearing aid industry. By integrating Intricon’s established technology, firmware, patented intellectual property, and algorithms, Jinghao gains a robust technological foundation that will enhance its global presence and product offerings. The addition of Intricon’s skilled team further strengthens Jinghao’s capabilities, bringing valuable expertise that will drive future innovation and ensure the company continues to deliver cutting-edge solutions to its customers.
For Jinghao’s customers, this acquisition brings several advantages. By integrating Intricon’s product lines, Jinghao will offer a broader range of hearing health solutions that cater to the diverse needs of customers worldwide. Additionally, the combined resources and strengthened global infrastructure will lead to more efficient service and support, ensuring faster and more effective responses to customer needs. Over time, customers will benefit from enhanced product offerings, improved services, and potentially lower costs as a result of the integration and scaling efforts.
Key Highlights of Intricon’s Hearing Health Business
Intricon’s Hearing Health business boasts several key strengths. With 47 years of proven innovation, the company has significantly influenced the hearing health industry through its patented intellectual property, firmware, and algorithms. Intricon has cultivated long-term relationships with leading original equipment manufacturers (OEMs) and emerging innovators, serving as a primary supplier to most of the “Big Five” audiology manufacturers. The company has also experienced continuous growth, actively participating in next-generation hearing aid programs and positioning itself to take advantage of the expanding over-the-counter (OTC) hearing health market. With global operations in Singapore and Indonesia, Intricon provides seamless service across multiple markets, and its strong industry reputation is underscored by an average customer tenure of over 20 years with its top five clients.
Vision for the Future and Invitation for Cooperation
With this acquisition, Jinghao Medical is poised to lead the global hearing health industry by delivering cutting-edge technology and customer-focused solutions. By integrating the strengths of both companies, Jinghao aims to drive further innovation in hearing health, making advanced, affordable hearing aids accessible to a larger market worldwide.
Invitation for Cooperation:
Jinghao Medical welcomes new partnerships and collaborations in the hearing health sector. We sincerely invite healthcare professionals, distributors, and technology innovators to join us in our mission to improve hearing health solutions for millions of people globally!
The article comes from the Internet. If there is any infringement, please contact service@jhhearingaids.com to delete it.
